All News

Ken Perez, MBA, vice president of healthcare policy and government affairs at Omnicell, outlined what has led to legislation granting pharmacists provider status gaining bipartisan support.

Being clear on your goals as a mentee while creating a partnership with your mentor is just one of the ways to have a successful mentorship.

In addition to concerns about the data supporting the FDA approval of aducanumab for patients with Alzheimer disease, FDA advisory committee members raised some unique concerns when they rejected the application in November 2020.

The shift to telemedicine for patient care for individuals with diabetes showed little negative impact on the metabolic health of these patients.

Many HTCs use these drug pricing arrangements to reduce reliance on limited federal funding.

The FDA has approved the first and only intravenous immunoglobulin indicated for use in adults with dermatomyositis.

Kevin Day, PharmD, president of Day’s Miami Heights Pharmacy in Cincinnati, Ohio, discusses how his independent pharmacy is gearing up for influenza season while continuing to deliver COVID-19 vaccines safely.

This month's featured products include an ophthalmic solution, darifenacin ER tablets, and more.

Study findings could offer a new approach to the toxin-based approach of other C. difficile vaccines in development.

Specific communication among different brain regions, known as brain connectivity, could potentially serve as a biomarker for attention-deficit hyperactivity disorder (ADHD), according to a study published in Frontiers in Physiology.

The drug is an investigational oral hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI) for patients with anemia due to chronic kidney disease (CKD).

Zydelig (idelalisib) is a kinase inhibitor approved in 2014 for 3 oncology indications.

HR 841 has bipartisan support, ensuring the FDA recognizes the products as dietary supplements.

Despite the FDA's approval of aducanumab for the treatment of Alzheimer disease with mild cognitive impairments, it has been surrounded by questions.

Trial identifies no new safety signals, as emicizumab continues to demonstrate effective bleeding control with a high proportion of participants achieving zero treated bleeds.

Ten quiz questions to assess your knowledge on common treatments and counseling points for heart failure.

PBMs can implement a clinically rigorous approach to specialty pharmacy management that ensures members have appropriate access while helping payers control their pharmacy spend.

Since the start of the pandemic, politicization and misinformation have led to hesitancy about the COVID-19 vaccine. However, vaccine hesitancy is not a new behavior.

Mary Reed, DrPH, research scientist at Kaiser Permanente, discussed what changes would be necessary to continue providing quality virtual health care to patients with diabetes.

Cabozantinib (Cabometyx, Exelixis) is a kinase inhibitor approved for indications such as advanced renal cell carcinoma and hepatocellular carcinoma.

Clinicians cite long-term complications and younger patients with better prognoses as reasons to pull back on oropharyngeal cancer therapy.

The FDA has approved finerenone for the treatment of adult patients with chronic kidney disease associated with type 2 diabetes.

By adequately working with students in advance and giving them ample opportunities to practice, pharmacy schools can prepare students for the future of the profession.

The 22F and 33F serotypes, which are associated with high rates of invasiveness and antibiotic resistance, are unique to the pneumococcal 15-valent conjugate vaccine.

The research team analyzed data from the Household Pulse Survey in March 2021, which is an online nationally representative sample of the population conducted by the US Census Bureau and the National Center for Health Statistics and other agencies.

When a medication, intended for another patient, is dispensed in error, is the pharmacy liable?

Clive Ward Able, MD, BPharm, president of Clintell, consultant to NeonMind Inc, and a trained pharmacist and physician, discusses his research into the use of psychedelic compounds to treat obesity.

Pharmacy Times interviewed Craig Freyer, PharmD, BCOP, a clinical pharmacy specialist at Penn Medicine in the University of Pennsylvania Health System, and Andrew Lin, PharmD, BCOP, an oncology pharmacy specialist at Memorial Sloan-Kettering Cancer Center, to provide an overview of current CAR T-cell therapies.